| R. Mark Adams, PhD. | ||
|
R. Mark Adams has been in the field of
bioinformatics for more than 10 years with extensive experience
in the design and implementation of large-scale informatics systems,
including regulated systems for use in clinical trials and the management
of high- throughput laboratory processes. Additionally, his academic
work has encompassed abstract mathematical and computational analysis of
molecular genetic and protein structure. His scientific work has resulted
in many patent applications, with several patents granted. As a
biotechnology executive Mark has extensive experience in the strategic
leadership and management of scientific and technical teams, having managed
teams of up to 50 biologists and computer scientists designing and
implementing high-throughput molecular biology and bioinformatics systems.
In his role as vice-president of the public biotechnology company,
Variagenics (now Nuvelo,) Mark
served on the executive committee, chartered with creating and executing a
strategic plan for cancer pharmacogenomics. Mark earned his Ph.D. in cell biology at Baylor College of Medicine in Houston, TX. His postdoctoral work with Temple Smith at the Biomolecular Engineering Research Center focused on computational protein functional determination. He is also an active member of the field of bioinformatics where he speaks and publishes frequently. He is also an editor of the journals Briefings in Bioinformatics and Applied Analytics in Consulting.
See my obituary page for William S. Burroughs here.
Mark can be reached via email at: |
|
|